Cargando…
Repurposed GI Drugs in the Treatment of COVID-19
Autores principales: | Aguila, Enrik John T., Cua, Ian Homer Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324004/ https://www.ncbi.nlm.nih.gov/pubmed/32601778 http://dx.doi.org/10.1007/s10620-020-06430-z |
Ejemplares similares
-
The Dilemma in the Management of Gastrointestinal Bleeding During the COVID-19 Pandemic
por: Aguila, Enrik John T., et al.
Publicado: (2021) -
Different barriers to nutritional therapy among critically-ill patients with COVID-19
por: Aguila, Enrik John T., et al.
Publicado: (2021) -
Repurposing existing drugs for COVID-19: an endocrinology perspective
por: Cadegiani, Flavio A.
Publicado: (2020) -
GI Training in the COVID-19 Era: A Problem of Global Concern
por: Marasco, Giovanni, et al.
Publicado: (2020) -
Repurposing cholesterol lowering drugs in the treatment and management of monkeypox
por: Sekaran, Saravanan, et al.
Publicado: (2023)